Exercise, IMA and Sulfhydryl Biomarkers in Young Women
IMA-SH & Exerc
Effects of Regular Exercise on Ischemia-Modified Albumin and Total Sulfhydryl Levels in Young Women
1 other identifier
observational
30
1 country
1
Brief Summary
Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) are increasingly recognized as sensitive biomarkers reflecting oxidative protein modification and thiol-dependent antioxidant capacity, respectively. However, data on their interplay in young women engaged in structured exercise remain scarce. Objective: This study aimed to investigate the effects of regular exercise on serum IMA and -SH concentrations in healthy young women, thereby providing insights into exercise-induced redox remodeling and sex-specific physiological adaptations. Methods: A cross-sectional design was employed involving 30 healthy women aged 18-25 years. Participants were divided into an exercise group (n = 15), who had performed structured training ≥3 sessions per week for at least one year, and a control group (n = 15) with no structured exercise history. Venous blood samples were collected after overnight fasting. Serum IMA was quantified using the albumin-cobalt binding assay, and -SH concentrations were determined via the Ellman method. All analyses were performed in duplicate under standardized laboratory conditions. Independent samples t-tests were applied, and effect sizes (Cohen's d) were calculated with 95% confidence intervals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2022
CompletedFirst Submitted
Initial submission to the registry
September 4, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedSeptember 23, 2025
September 1, 2025
1 month
September 4, 2025
September 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum Ischemia-Modified Albumin (IMA)
Change in serum ischemia-modified albumin (IMA) concentration, measured in absorbance units (ABSU) using the albumin-cobalt binding assay.
Baseline (single fasting blood draw)
Secondary Outcomes (1)
Serum Total Sulfhydryl Groups (-SH)
Baseline (single fasting blood draw)
Study Arms (2)
Exercising Women
Healthy women aged 18-25 years who performed structured exercise training ≥3 sessions per week for at least 12 months. Training programs included aerobic, resistance, and flexibility exercise, each session lasting 60-90 minutes.
Sedentary Controls
Healthy women aged 18-25 years without a history of structured exercise. Physical activity limited to daily living and compulsory school-based physical education classes.
Eligibility Criteria
Thirty healthy women aged 18-25 years were recruited. Fifteen had a history of regular structured exercise training, while fifteen had sedentary lifestyles without structured exercise.
You may qualify if:
- Healthy women aged 18-25 years
- For exercise group: Regular structured training ≥3 sessions per week for at least 12 months
- For control group: No structured exercise background, only daily living activity
You may not qualify if:
- History of chronic cardiovascular, metabolic, or endocrine disorders
- Smoking or alcohol abuse
- Current or recent use (past 6 months) of medications or supplements influencing oxidative stress or hormonal regulation
- Irregular or intermittent exercise participation not meeting the defined threshold
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yüzüncü Yıl University, Central Research Laboratory
Van, Muş, 49100, Turkey (Türkiye)
Related Publications (1)
Bilici OF, Kahraman MZ, Turker A, Seyhan S, Sahin MF, Demir H, Acar G, Bilici MF, Soylu C, Sogut T, Bakum A. Effects of regular exercise on ischemia-modified albumin and total sulfhydryl levels in young women: a cross-sectional study. Front Physiol. 2025 Nov 20;16:1719454. doi: 10.3389/fphys.2025.1719454. eCollection 2025.
PMID: 41357165DERIVED
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 4, 2025
First Posted
September 18, 2025
Study Start
January 20, 2022
Primary Completion
February 20, 2022
Study Completion
March 20, 2022
Last Updated
September 23, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because the study involved a small sample of healthy young women and includes sensitive biomarker information. Data sharing is restricted by the ethics committee approval and participant consent, which did not authorize public distribution of individual-level data.